[Pharmacokinetic of platin in plasma and urine of man under 1-, 8-, and 24 h-infusion with cis-dichlorodiamine-platin (II) (cis-DDP) (author's transl)]

Klin Wochenschr. 1982 Mar 1;60(5):247-55. doi: 10.1007/BF01728344.
[Article in German]

Abstract

Concentrations of platin were determined with the method of atomic absorption spectroscopy in plasma and urine from the 1st until 28th day after cis-DDP (3 mg/kg) infusion for 1, 8, and 24 h. Maximum of plasma concentration was measured always at the end of the application time. Minimal concentration was 1.9 micrograms/ml, maximal concentration 5.8 micrograms/ml. Platin could be detected until the 21st respectively 28th day between 0.01 and 0.9 micrograms/ml. The duration of cis-DDP infusions was without influence on the mean excretion of platin. Between 24 and 25% of the infused platin was excreted after 24 h, between 4.8 and 7% after further 24 h, between 1 and 2% between the 3rd and 21st day, and less than 1% thereafter. Difference in pattern of toxicity could not be clearly detected.

Publication types

  • English Abstract

MeSH terms

  • Adult
  • Carcinoma, Squamous Cell / drug therapy
  • Cisplatin / therapeutic use*
  • Female
  • Head and Neck Neoplasms / drug therapy
  • Humans
  • Infusions, Parenteral
  • Kinetics
  • Lung Neoplasms / drug therapy
  • Lymphoma / drug therapy
  • Male
  • Middle Aged
  • Ovarian Neoplasms / drug therapy
  • Platinum / blood
  • Platinum / metabolism*
  • Platinum / urine
  • Testicular Neoplasms / drug therapy

Substances

  • Platinum
  • Cisplatin